|
|
|
AbbVie
|
Stand/Booth No. 23 & 44
|
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. AbbVie employs more than 26,000 people worldwide and markets medicines in more than 170 countries. Our heritage in Australia reaches back more than 75 years and we employ more than 225 people here with a focus on Immunology, Liver Disease, Neuroscience and Oncology, and our therapies currently benefit more than 32,000 Australians. For further information on the company and its people, portfolio and commitments, please visit http://www.abbvie.com.au. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
